nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CHRM2—type 1 diabetes mellitus	0.673	1	CbGaD
Doxepin—Lower respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00538	0.0546	CcSEcCtD
Doxepin—HTR2A—arteriole—type 1 diabetes mellitus	0.00395	0.121	CbGeAlD
Doxepin—ORM1—saliva—type 1 diabetes mellitus	0.00366	0.112	CbGeAlD
Doxepin—Inappropriate antidiuretic hormone secretion—Ramipril—type 1 diabetes mellitus	0.00316	0.0321	CcSEcCtD
Doxepin—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.00281	0.0863	CbGeAlD
Doxepin—Bone marrow depression—Ramipril—type 1 diabetes mellitus	0.00272	0.0276	CcSEcCtD
Doxepin—Ageusia—Ramipril—type 1 diabetes mellitus	0.00227	0.023	CcSEcCtD
Doxepin—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.00212	0.0215	CcSEcCtD
Doxepin—Jaundice cholestatic—Ramipril—type 1 diabetes mellitus	0.00209	0.0212	CcSEcCtD
Doxepin—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.00193	0.0196	CcSEcCtD
Doxepin—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00169	0.0519	CbGeAlD
Doxepin—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00164	0.0167	CcSEcCtD
Doxepin—SLC6A2—nerve—type 1 diabetes mellitus	0.00158	0.0486	CbGeAlD
Doxepin—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.0015	0.0153	CcSEcCtD
Doxepin—Deafness—Ramipril—type 1 diabetes mellitus	0.00149	0.0151	CcSEcCtD
Doxepin—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00149	0.0151	CcSEcCtD
Doxepin—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.00148	0.015	CcSEcCtD
Doxepin—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00146	0.0149	CcSEcCtD
Doxepin—DRD2—nerve—type 1 diabetes mellitus	0.00144	0.0442	CbGeAlD
Doxepin—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00144	0.0146	CcSEcCtD
Doxepin—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00143	0.044	CbGeAlD
Doxepin—Purpura—Ramipril—type 1 diabetes mellitus	0.00138	0.014	CcSEcCtD
Doxepin—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00136	0.0138	CcSEcCtD
Doxepin—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00132	0.0134	CcSEcCtD
Doxepin—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00122	0.0374	CbGeAlD
Doxepin—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00121	0.0122	CcSEcCtD
Doxepin—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.0012	0.0122	CcSEcCtD
Doxepin—Influenza—Ramipril—type 1 diabetes mellitus	0.00115	0.0117	CcSEcCtD
Doxepin—Asthma—Ramipril—type 1 diabetes mellitus	0.00115	0.0117	CcSEcCtD
Doxepin—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00114	0.0116	CcSEcCtD
Doxepin—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00111	0.0113	CcSEcCtD
Doxepin—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00109	0.0111	CcSEcCtD
Doxepin—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00107	0.0109	CcSEcCtD
Doxepin—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00106	0.0108	CcSEcCtD
Doxepin—HRH2—cardiovascular system—type 1 diabetes mellitus	0.00105	0.0322	CbGeAlD
Doxepin—Weight increased—Ramipril—type 1 diabetes mellitus	0.00105	0.0106	CcSEcCtD
Doxepin—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00101	0.0102	CcSEcCtD
Doxepin—Stomatitis—Ramipril—type 1 diabetes mellitus	0.001	0.0102	CcSEcCtD
Doxepin—Jaundice—Ramipril—type 1 diabetes mellitus	0.001	0.0102	CcSEcCtD
Doxepin—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.000999	0.0101	CcSEcCtD
Doxepin—Dimetindene—CHRM2—type 1 diabetes mellitus	0.000994	0.171	CrCbGaD
Doxepin—Sweating—Ramipril—type 1 diabetes mellitus	0.000985	0.01	CcSEcCtD
Doxepin—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000972	0.00987	CcSEcCtD
Doxepin—Sinusitis—Ramipril—type 1 diabetes mellitus	0.000964	0.00979	CcSEcCtD
Doxepin—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000959	0.00974	CcSEcCtD
Doxepin—HTR2A—nerve—type 1 diabetes mellitus	0.000951	0.0292	CbGeAlD
Doxepin—Hepatitis—Ramipril—type 1 diabetes mellitus	0.000923	0.00936	CcSEcCtD
Doxepin—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000909	0.00923	CcSEcCtD
Doxepin—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000907	0.0092	CcSEcCtD
Doxepin—ADRA1B—kidney—type 1 diabetes mellitus	0.000897	0.0275	CbGeAlD
Doxepin—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00086	0.00873	CcSEcCtD
Doxepin—Flushing—Ramipril—type 1 diabetes mellitus	0.000856	0.00869	CcSEcCtD
Doxepin—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.000833	0.00846	CcSEcCtD
Doxepin—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000832	0.00844	CcSEcCtD
Doxepin—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000824	0.00837	CcSEcCtD
Doxepin—Alopecia—Ramipril—type 1 diabetes mellitus	0.000815	0.00828	CcSEcCtD
Doxepin—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000808	0.0082	CcSEcCtD
Doxepin—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000803	0.00815	CcSEcCtD
Doxepin—Erythema—Ramipril—type 1 diabetes mellitus	0.000803	0.00815	CcSEcCtD
Doxepin—Tension—Ramipril—type 1 diabetes mellitus	0.000788	0.008	CcSEcCtD
Doxepin—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000787	0.00798	CcSEcCtD
Doxepin—Nervousness—Ramipril—type 1 diabetes mellitus	0.00078	0.00792	CcSEcCtD
Doxepin—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000772	0.00784	CcSEcCtD
Doxepin—Tremor—Ramipril—type 1 diabetes mellitus	0.000753	0.00764	CcSEcCtD
Doxepin—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000745	0.00756	CcSEcCtD
Doxepin—Agitation—Ramipril—type 1 diabetes mellitus	0.000738	0.00749	CcSEcCtD
Doxepin—Malaise—Ramipril—type 1 diabetes mellitus	0.000724	0.00735	CcSEcCtD
Doxepin—Vertigo—Ramipril—type 1 diabetes mellitus	0.000722	0.00732	CcSEcCtD
Doxepin—Syncope—Ramipril—type 1 diabetes mellitus	0.00072	0.00731	CcSEcCtD
Doxepin—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000719	0.0073	CcSEcCtD
Doxepin—Palpitations—Ramipril—type 1 diabetes mellitus	0.00071	0.0072	CcSEcCtD
Doxepin—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000706	0.00717	CcSEcCtD
Doxepin—Cough—Ramipril—type 1 diabetes mellitus	0.000701	0.00711	CcSEcCtD
Doxepin—Convulsion—Ramipril—type 1 diabetes mellitus	0.000696	0.00706	CcSEcCtD
Doxepin—CHRM2—cardiovascular system—type 1 diabetes mellitus	0.000689	0.0211	CbGeAlD
Doxepin—KCNH2—islet of Langerhans—type 1 diabetes mellitus	0.000688	0.0211	CbGeAlD
Doxepin—Myalgia—Ramipril—type 1 diabetes mellitus	0.000684	0.00694	CcSEcCtD
Doxepin—Chest pain—Ramipril—type 1 diabetes mellitus	0.000684	0.00694	CcSEcCtD
Doxepin—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000684	0.00694	CcSEcCtD
Doxepin—Anxiety—Ramipril—type 1 diabetes mellitus	0.000681	0.00692	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000679	0.00689	CcSEcCtD
Doxepin—Discomfort—Ramipril—type 1 diabetes mellitus	0.000676	0.00686	CcSEcCtD
Doxepin—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000669	0.00679	CcSEcCtD
Doxepin—Confusional state—Ramipril—type 1 diabetes mellitus	0.000661	0.00671	CcSEcCtD
Doxepin—Oedema—Ramipril—type 1 diabetes mellitus	0.000656	0.00665	CcSEcCtD
Doxepin—Shock—Ramipril—type 1 diabetes mellitus	0.000645	0.00655	CcSEcCtD
Doxepin—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000643	0.00652	CcSEcCtD
Doxepin—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000642	0.00651	CcSEcCtD
Doxepin—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00064	0.00649	CcSEcCtD
Doxepin—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000637	0.00646	CcSEcCtD
Doxepin—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000634	0.00643	CcSEcCtD
Doxepin—CHRM1—cardiovascular system—type 1 diabetes mellitus	0.000627	0.0192	CbGeAlD
Doxepin—Anorexia—Ramipril—type 1 diabetes mellitus	0.000625	0.00634	CcSEcCtD
Doxepin—HTR2B—cardiovascular system—type 1 diabetes mellitus	0.000624	0.0191	CbGeAlD
Doxepin—Hypotension—Ramipril—type 1 diabetes mellitus	0.000613	0.00622	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000597	0.00606	CcSEcCtD
Doxepin—DRD2—retina—type 1 diabetes mellitus	0.000597	0.0183	CbGeAlD
Doxepin—Insomnia—Ramipril—type 1 diabetes mellitus	0.000593	0.00602	CcSEcCtD
Doxepin—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000589	0.00597	CcSEcCtD
Doxepin—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000584	0.00593	CcSEcCtD
Doxepin—Somnolence—Ramipril—type 1 diabetes mellitus	0.000583	0.00591	CcSEcCtD
Doxepin—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000577	0.00586	CcSEcCtD
Doxepin—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00057	0.00578	CcSEcCtD
Doxepin—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000566	0.00574	CcSEcCtD
Doxepin—Fatigue—Ramipril—type 1 diabetes mellitus	0.000565	0.00574	CcSEcCtD
Doxepin—Constipation—Ramipril—type 1 diabetes mellitus	0.000561	0.00569	CcSEcCtD
Doxepin—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.000559	0.0172	CbGeAlD
Doxepin—CHRM3—kidney—type 1 diabetes mellitus	0.000549	0.0169	CbGeAlD
Doxepin—ADRA2C—nephron tubule—type 1 diabetes mellitus	0.000547	0.0168	CbGeAlD
Doxepin—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.000542	0.0166	CbGeAlD
Doxepin—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00054	0.00548	CcSEcCtD
Doxepin—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000536	0.00544	CcSEcCtD
Doxepin—Urticaria—Ramipril—type 1 diabetes mellitus	0.000521	0.00529	CcSEcCtD
Doxepin—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000518	0.00526	CcSEcCtD
Doxepin—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000518	0.00526	CcSEcCtD
Doxepin—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.000515	0.0158	CbGeAlD
Doxepin—KCNH2—cardiovascular system—type 1 diabetes mellitus	0.000498	0.0153	CbGeAlD
Doxepin—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000483	0.0049	CcSEcCtD
Doxepin—ADRA2C—kidney—type 1 diabetes mellitus	0.00048	0.0147	CbGeAlD
Doxepin—ADRA2C—pancreas—type 1 diabetes mellitus	0.000477	0.0146	CbGeAlD
Doxepin—Asthenia—Ramipril—type 1 diabetes mellitus	0.00047	0.00477	CcSEcCtD
Doxepin—Chlorprothixene—CHRM2—type 1 diabetes mellitus	0.00047	0.081	CrCbGaD
Doxepin—Pruritus—Ramipril—type 1 diabetes mellitus	0.000464	0.00471	CcSEcCtD
Doxepin—Nortriptyline—CHRM2—type 1 diabetes mellitus	0.000462	0.0795	CrCbGaD
Doxepin—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000449	0.00455	CcSEcCtD
Doxepin—Dizziness—Ramipril—type 1 diabetes mellitus	0.000433	0.0044	CcSEcCtD
Doxepin—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.000433	0.0133	CbGeAlD
Doxepin—Diphenhydramine—CHRM2—type 1 diabetes mellitus	0.000427	0.0735	CrCbGaD
Doxepin—Promethazine—CHRM2—type 1 diabetes mellitus	0.000418	0.0721	CrCbGaD
Doxepin—Vomiting—Ramipril—type 1 diabetes mellitus	0.000417	0.00423	CcSEcCtD
Doxepin—Rash—Ramipril—type 1 diabetes mellitus	0.000413	0.0042	CcSEcCtD
Doxepin—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000413	0.00419	CcSEcCtD
Doxepin—Headache—Ramipril—type 1 diabetes mellitus	0.000411	0.00417	CcSEcCtD
Doxepin—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.000404	0.0124	CbGeAlD
Doxepin—Orphenadrine—CHRM2—type 1 diabetes mellitus	0.000404	0.0695	CrCbGaD
Doxepin—HTR2A—retina—type 1 diabetes mellitus	0.000394	0.0121	CbGeAlD
Doxepin—Nausea—Ramipril—type 1 diabetes mellitus	0.000389	0.00395	CcSEcCtD
Doxepin—ADRA2A—pancreas—type 1 diabetes mellitus	0.000381	0.0117	CbGeAlD
Doxepin—Desipramine—CHRM2—type 1 diabetes mellitus	0.00038	0.0655	CrCbGaD
Doxepin—Promazine—CHRM2—type 1 diabetes mellitus	0.000368	0.0634	CrCbGaD
Doxepin—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.000333	0.0102	CbGeAlD
Doxepin—HTR2A—kidney—type 1 diabetes mellitus	0.000326	0.01	CbGeAlD
Doxepin—Desipramine—ADRB1—type 1 diabetes mellitus	0.000324	0.0558	CrCbGaD
Doxepin—Imipramine—CHRM2—type 1 diabetes mellitus	0.000322	0.0555	CrCbGaD
Doxepin—Amitriptyline—CHRM2—type 1 diabetes mellitus	0.00032	0.0552	CrCbGaD
Doxepin—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000302	0.00926	CbGeAlD
Doxepin—CYP3A4—kidney—type 1 diabetes mellitus	0.000302	0.00926	CbGeAlD
Doxepin—CYP2D6—kidney—type 1 diabetes mellitus	0.000297	0.00911	CbGeAlD
Doxepin—Oxcarbazepine—ALB—type 1 diabetes mellitus	0.000282	0.0485	CrCbGaD
Doxepin—ABCB1—retina—type 1 diabetes mellitus	0.000258	0.00792	CbGeAlD
Doxepin—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000243	0.00746	CbGeAlD
Doxepin—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000218	0.0067	CbGeAlD
Doxepin—ABCB1—kidney—type 1 diabetes mellitus	0.000214	0.00656	CbGeAlD
Doxepin—ABCB1—pancreas—type 1 diabetes mellitus	0.000212	0.00651	CbGeAlD
Doxepin—Thiothixene—ALB—type 1 diabetes mellitus	0.000205	0.0352	CrCbGaD
Doxepin—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000183	0.00563	CbGeAlD
Doxepin—Clomipramine—ALB—type 1 diabetes mellitus	0.000162	0.0279	CrCbGaD
Doxepin—Nortriptyline—ALB—type 1 diabetes mellitus	0.000158	0.0272	CrCbGaD
Doxepin—Amitriptyline—ALB—type 1 diabetes mellitus	0.00011	0.0189	CrCbGaD
Doxepin—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	9.35e-06	4.93e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.34e-06	4.93e-05	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	9.34e-06	4.93e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.33e-06	4.92e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.32e-06	4.92e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.31e-06	4.91e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.3e-06	4.91e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	9.28e-06	4.89e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.27e-06	4.89e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.27e-06	4.89e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	9.27e-06	4.89e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.24e-06	4.88e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.22e-06	4.87e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.2e-06	4.85e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.18e-06	4.84e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	9.16e-06	4.83e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.15e-06	4.83e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.13e-06	4.82e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—ALB—type 1 diabetes mellitus	9.1e-06	4.8e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	9.08e-06	4.79e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	9.03e-06	4.76e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—INS—type 1 diabetes mellitus	8.88e-06	4.69e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.82e-06	4.65e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.79e-06	4.64e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—INS—type 1 diabetes mellitus	8.78e-06	4.63e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CD80—type 1 diabetes mellitus	8.78e-06	4.63e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—NOS3—type 1 diabetes mellitus	8.7e-06	4.59e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	8.67e-06	4.57e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	8.64e-06	4.56e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.63e-06	4.55e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.63e-06	4.55e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL2—type 1 diabetes mellitus	8.61e-06	4.54e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	8.6e-06	4.54e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.59e-06	4.53e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.59e-06	4.53e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	8.58e-06	4.52e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.57e-06	4.52e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.55e-06	4.51e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	8.55e-06	4.51e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	8.53e-06	4.5e-05	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—IL6—type 1 diabetes mellitus	8.51e-06	4.49e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	8.48e-06	4.47e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	8.4e-06	4.43e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	8.35e-06	4.4e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	8.3e-06	4.38e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.29e-06	4.38e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.25e-06	4.35e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.25e-06	4.35e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.21e-06	4.33e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	8.17e-06	4.31e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.14e-06	4.29e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL2—type 1 diabetes mellitus	8.12e-06	4.29e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.08e-06	4.26e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	8.06e-06	4.25e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—ALB—type 1 diabetes mellitus	8.05e-06	4.25e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.03e-06	4.23e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.99e-06	4.21e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	7.97e-06	4.2e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.94e-06	4.19e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	7.92e-06	4.18e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	7.91e-06	4.17e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.9e-06	4.17e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.87e-06	4.15e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL2—type 1 diabetes mellitus	7.86e-06	4.15e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.86e-06	4.15e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	7.86e-06	4.15e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	7.84e-06	4.14e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	7.84e-06	4.14e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	7.82e-06	4.13e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.82e-06	4.13e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	7.81e-06	4.12e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	7.8e-06	4.11e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.79e-06	4.11e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.79e-06	4.11e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL2—type 1 diabetes mellitus	7.78e-06	4.1e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CD80—type 1 diabetes mellitus	7.77e-06	4.1e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.74e-06	4.08e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—NOS3—type 1 diabetes mellitus	7.7e-06	4.06e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	7.7e-06	4.06e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	7.68e-06	4.05e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	7.67e-06	4.05e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.66e-06	4.04e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.62e-06	4.02e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	7.53e-06	3.97e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.52e-06	3.97e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.48e-06	3.95e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.41e-06	3.91e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	7.41e-06	3.91e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	7.39e-06	3.9e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	7.39e-06	3.9e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	7.37e-06	3.89e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—INS—type 1 diabetes mellitus	7.35e-06	3.87e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.33e-06	3.86e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL2—type 1 diabetes mellitus	7.31e-06	3.86e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.3e-06	3.85e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.28e-06	3.84e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.28e-06	3.84e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.28e-06	3.84e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	7.27e-06	3.84e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	7.25e-06	3.83e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.25e-06	3.82e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.25e-06	3.82e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.17e-06	3.78e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.16e-06	3.78e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.15e-06	3.77e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	7.13e-06	3.76e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.13e-06	3.76e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.13e-06	3.76e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.12e-06	3.75e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.1e-06	3.75e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.09e-06	3.74e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.07e-06	3.73e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	7.07e-06	3.73e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.04e-06	3.71e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.02e-06	3.7e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7e-06	3.69e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.98e-06	3.68e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.84e-06	3.61e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	6.74e-06	3.56e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.73e-06	3.55e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	6.7e-06	3.54e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.62e-06	3.49e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.62e-06	3.49e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.61e-06	3.49e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.6e-06	3.48e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	6.6e-06	3.48e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.6e-06	3.48e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—IL6—type 1 diabetes mellitus	6.6e-06	3.48e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.59e-06	3.47e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.58e-06	3.47e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.57e-06	3.47e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.56e-06	3.46e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.55e-06	3.45e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.52e-06	3.44e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.5e-06	3.43e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.5e-06	3.43e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.49e-06	3.42e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.48e-06	3.42e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.48e-06	3.42e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.46e-06	3.41e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.44e-06	3.4e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.38e-06	3.37e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.38e-06	3.37e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	6.38e-06	3.36e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.36e-06	3.36e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.35e-06	3.35e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.34e-06	3.35e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	6.34e-06	3.35e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.31e-06	3.33e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.21e-06	3.28e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.18e-06	3.26e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	6.17e-06	3.25e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.16e-06	3.25e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.14e-06	3.24e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	6.11e-06	3.22e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.08e-06	3.21e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	6.07e-06	3.2e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.04e-06	3.19e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.02e-06	3.18e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.01e-06	3.17e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.95e-06	3.14e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.91e-06	3.12e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	5.71e-06	3.01e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.61e-06	2.96e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	5.6e-06	2.95e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.59e-06	2.95e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—INS—type 1 diabetes mellitus	5.57e-06	2.94e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.57e-06	2.94e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.56e-06	2.93e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.52e-06	2.91e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	5.51e-06	2.91e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.5e-06	2.9e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	5.5e-06	2.9e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.49e-06	2.89e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.48e-06	2.89e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	5.48e-06	2.89e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.47e-06	2.89e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.47e-06	2.88e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL2—type 1 diabetes mellitus	5.46e-06	2.88e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.45e-06	2.88e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.43e-06	2.87e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.42e-06	2.86e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	5.41e-06	2.85e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.4e-06	2.85e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	5.39e-06	2.84e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.38e-06	2.84e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.37e-06	2.83e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.36e-06	2.83e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.34e-06	2.82e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	5.25e-06	2.77e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	5.24e-06	2.76e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	5.21e-06	2.75e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.19e-06	2.74e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	5.17e-06	2.73e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	5.11e-06	2.7e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.11e-06	2.7e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	5.06e-06	2.67e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.05e-06	2.66e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.02e-06	2.65e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	5.01e-06	2.64e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	5.01e-06	2.64e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.99e-06	2.63e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	4.89e-06	2.58e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.88e-06	2.57e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.85e-06	2.56e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	4.82e-06	2.54e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—type 1 diabetes mellitus	4.78e-06	2.52e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	4.77e-06	2.52e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.72e-06	2.49e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.71e-06	2.48e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.64e-06	2.45e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.63e-06	2.44e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.62e-06	2.44e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—type 1 diabetes mellitus	4.62e-06	2.44e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.61e-06	2.43e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	4.61e-06	2.43e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.6e-06	2.42e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—type 1 diabetes mellitus	4.57e-06	2.41e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	4.57e-06	2.41e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.55e-06	2.4e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.54e-06	2.39e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	4.45e-06	2.35e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—type 1 diabetes mellitus	4.3e-06	2.27e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.28e-06	2.26e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.22e-06	2.22e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.21e-06	2.22e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.2e-06	2.22e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.19e-06	2.21e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.18e-06	2.2e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.14e-06	2.18e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.12e-06	2.18e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	4.08e-06	2.15e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	3.9e-06	2.06e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.88e-06	2.05e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.83e-06	2.02e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.75e-06	1.98e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	3.73e-06	1.97e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	3.63e-06	1.91e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.57e-06	1.88e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	3.43e-06	1.81e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	3.29e-06	1.74e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.24e-06	1.71e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.23e-06	1.7e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.22e-06	1.7e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—type 1 diabetes mellitus	3.21e-06	1.69e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	3.18e-06	1.68e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.17e-06	1.67e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	3.15e-06	1.66e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	3.01e-06	1.59e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.95e-06	1.55e-05	CbGpPWpGaD
